An Investigational New Drug (IND) is a pharmaceutical compound that has undergone laboratory and animal testing and has been approved by the FDA to begin testing in humans. The primary goal of the IND process is to ensure that the potential drug is safe to administer to humans and holds promise for treating the targeted condition, such as cancer.
